October 25, 2026 11:15 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Jamia shifts classes online after clash over demand for student union polls; Congress MPs face allegations | Deadly mid-air collision: Four pilots killed as two military aircraft crash in Philippines | ‘Jihad’ calls, Modi assassination remarks: Mumbai Rapido driver arrested over alleged Jaish links | Vegetarian-only kitchen at Keralam Lok Bhavan? Governor's reported order triggers political backlash | ‘Another little Epic Fury’: Trump’s chilling warning to Iran as fresh US strikes loom | Bomb threat email names Amitabh Bachchan’s Jalsa bungalow, Diljit Dosanjh’s concert venue: Reports | ‘Face-offs still continue’: ITBP chief reveals fresh India-China border tensions in Arunachal | Eiffel Tower women staff row: BAPS monk blames ‘miscommunication’, denies delegation's role | ‘Pen, not stones and guns’: RSS-linked group opens its first office in Kashmir Valley under Muslim leader | First human case of Shamonda virus reported in France; WHO confirms death of immunocompromised patient
Sputnik V | Namibia
Image Credit: twitter page Sputnik V

After South Africa, Namibia also suspends use of Russia's Sputnik V vaccine

| @indiablooms | Oct 25, 2021, at 01:05 am

After South Africa, Namibia has stopped Russia's Sputnik V Covid-19 vaccine citing concerns that it could increase the risk of HIV infection among men, a claim the vaccine's manufacturer says is unfounded, according to media reports.

The Namibian health ministry said in a statement that following South Africa's decision it was suspending, with immediate effect, the use of the jabs until the formula is listed for emergency use by the World Health Organization, reported AFP.

"The reason for discontinuation of the administration of the vaccine is being done out of abundance of caution that men who received Sputnik V may be at higher risk of contracting HIV when exposed to it," said the ministry.

Namibia had taken delivery of a Serbian donation of 30,000 Sputnik doses -- out of which less than 120 have been administered so far.

South Africa's health products regulator said the decision was based on two previous studies, one in South Africa and one in the Americas, on the modified form of adenovirus -- a type of virus that causes respiratory infections -- known as the Ad5 and contained in the jab.

In both trials, "administration of an Ad5-vectored vaccine was associated with enhanced susceptibility/acquisition of HIV in men", the regulator said last week, the AFP report stated.

Russia's Gamaleya Centre, which developed Sputnik V, stated it would bring to fore that SAHPRA's concerns were "completely unfounded".

"Speculation regarding the association between adenovirus type-5 vectored vaccines and HIV transmission in high risk groups has been based on small-scale studies," it said in a statement.    

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.